REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

by palligoelme@gmail.com | May 23, 2025 | Clinical Trials

​ Conditions: Bronchiectasis Adult Interventions: Biological: REGEND001 Autologous Basal Layer Stem Cell Suspension Sponsors: Ruijin Hospital Not yet recruiting Conditions: Bronchiectasis Adult Interventions: Biological: REGEND001 Autologous Basal Layer Stem Cell...

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma

by palligoelme@gmail.com | May 22, 2025 | Clinical Trials

​ Conditions: Severe Asthma Interventions: Combination Product: Hyperpolarized 129 Xenon Sponsors: University of Kansas Medical Center; Polarean Imaging, Plc Recruiting Conditions: Severe Asthma Interventions: Combination Product: Hyperpolarized 129 Xenon Sponsors:...

Photobiomodulation on Pain Perception During the Insertion of the T 380 Copper Intrauterine Device (IUD)

by palligoelme@gmail.com | May 22, 2025 | Clinical Trials

​ Conditions: Pain Interventions: Device: Photobiomodulation; Other: Simulation of Photobiomodulation Sponsors: University of Nove de Julho Not yet recruiting Conditions: Pain Interventions: Device: Photobiomodulation; Other: Simulation of Photobiomodulation Sponsors:...

Curcumin Supplementation for the Improvement of Diabetes-related Outcomes

by palligoelme@gmail.com | May 22, 2025 | Clinical Trials

​ Conditions: Over Age 60; Prediabetes or Overweight Interventions: Dietary Supplement: Curcumin; Dietary Supplement: Placebo Sponsors: Oklahoma State University Completed Conditions: Over Age 60; Prediabetes or Overweight Interventions: Dietary Supplement: Curcumin;...

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

by palligoelme@gmail.com | May 22, 2025 | Clinical Trials

​ Conditions: Triple-Negative Breast Cancer (TNBC); Neoadjuvant Chemotherapy; Chemotherapy Effects Interventions: Drug: nab-paclitaxel, carboplatin, and bemotuzumab; Drug: epirubicin, cyclophosphamide, and bemotuzumab Sponsors: Zhejiang Provincial People’s...